Guild Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-36,995
Closed -$2.55M 54
2025
Q2
$2.55M Buy
36,995
+6,345
+21% +$432K 2.22% 19
2025
Q1
$2.16M Sell
30,650
-2,303
-7% -$190K 2.27% 20
2024
Q4
$2.83M Buy
32,953
+7,191
+28% +$778K 3.09% 12
2024
Q3
$3.07M Buy
25,762
+1,312
+5% +$175K 3.37% 10
2024
Q2
$3.49M Sell
24,450
-26
-0.1% -$3.44K 3.99% 7
2024
Q1
$3.14M Buy
24,476
+7,710
+46% +$918K 4.02% 8
2023
Q4
$1.73M Buy
16,766
+12,852
+328% +$1.27M 2.75% 16
2023
Q3
$356K Buy
+3,914
New +$345K 0.6% 42

Other funds holding NVO

Guild Investment Management's NVO Position: Q3 2025 in Review

Guild Investment Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 36,995 shares — an estimated $2.55M sold.

Guild Investment Management first reported a position in NVO in Q3 2023 and held it in 8 quarters. The position peaked at $3.49M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Guild Investment Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Guild Investment Management sold 36,995 Novo Nordisk shares in Q3 2025, an estimated $2.55M.
  • Guild Investment Management first reported a position in Novo Nordisk in Q3 2023 and held it in 8 quarters.
  • Guild Investment Management's Novo Nordisk position peaked at $3.49M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Guild Investment Management's 13F filing for Q3 2025, filed 5 Nov 2025.